Advertisement

Topics

Xencor Incorporated Company Profile

10:45 EDT 26th September 2017 | BioPortfolio

Xencor™ is a biotechnology company that is commercializing Protein Design Automation™ (PDA), a proprietary research platform for protein design.

PDA builds on recent groundbreaking advances in computer capabilities and computational chemistry methods to design protein and peptide variants, as well as completely unique protein sequences. PDA produces novel proteins that preserve target functions while modifying selected chemical and biological properties. PDA can rapidly examine vastly more protein sequences than is possible for methods based on genetic screening and selection, resulting in a higher success rate and access to a wider range of novel protein properties.



Xencor's dedicated research facilities include a molecular biology laboratory and a state-of the art computational lab with a parallel supercomputer. Xencor has ongoing collaborations with leading universities, including the California Institute of Technology (Caltech) and the Massachusetts Institute of Technology (MIT).



Xencor is positioned to lead the field of rational biodiscovery by leveraging PDA into new biopharmaceutical and reagents, biomolecule product libraries, databases and proprietary R&D systems. Xencor holds the exclusive worldwide license for PDA technology

Location

2585 Nina Street
Pasadena
CA
91107-3708
United States of America

Contact

Phone: 626-744-5750
Fax: 626-744-5757


News Articles [25 Associated News Articles listed on BioPortfolio]

Xencor Licenses Fc Antibody Engineering IP to Merck

MONROVIA, Calif., July 2, 2013 /PRNewswire/ -- Xencor, Inc. announced today that that it has entered into a technology license and option agreement to provide Merck, known as MSD outside the United St...

Xencor to Present at Jefferies 2017 Global Healthcare Conference

MONROVIA, Calif., May 30, 2017 /PRNewswire/ -- Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimm...

Lead drug candidate from Xencor wins FDA orphan status

An orphan drug designation was granted by the FDA for Xencor's lead drug candidate, XmAB5871, as a treatment for patients wit -More- 

Xencor to Host Second Quarter 2017 Financial Results Webcast and Conference Call on August 7, 2017

MONROVIA, Calif., July 31, 2017 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoi...

Xencor, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Updated: 06052017] Prices from USD $350

Xencor, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Xencor, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes ...

Xencor, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 14062017] Prices from USD $350

Xencor, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Xencor, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes ...

Xencor reports interim positive results from Phase II trial of XmAb5871 for IgG4-RD

Biopharmaceutical firm Xencor has reported interim positive results from the Phase II clinical trial of XmAb5871 for the treatment of patients with active IgG4-Related Disease (IgG4-RD).

Can Xencor Continue To Rally?

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

AERODYNAMIC PROPERTIES AND IN SILICO DEPOSITION OF MELOXICAM POTASSIUM INCORPORATED IN A CARRIER-FREE DPI PULMONARY SYSTEM.

Dry powder inhalers (DPIs) have been among the fastest developing inhaler forms in the past decades. Researches are focusing on the formulation of carrier-free powders to obtain a higher deep-lung dep...

Clinical Trials [0 Results]

None

Companies [38 Associated Companies listed on BioPortfolio]

Xencor Incorporated

Xencor™ is a biotechnology company that is commercializing Protein Design Automation™ (PDA), a proprietary research platform for protein design. PDA builds on recent groundbreaking advances in co...

Xencor, Inc.

Xencor, Inc. engineers superior biotherapeutics using its proprietary Protein Design Automation® technology platform, and is a leader in the field of antibody engineering to si...

Xencor

Since 1997, Xencor has built the most powerful protein engineering technology platform in the biotechnology industry. Its versatility is evidenced by our success in developing two classes of superior ...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Pharmapraxis

Founded in 2008 by the Axis Biotec Brasil™ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....

More Information about "Xencor Incorporated" on BioPortfolio

We have published hundreds of Xencor Incorporated news stories on BioPortfolio along with dozens of Xencor Incorporated Clinical Trials and PubMed Articles about Xencor Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Xencor Incorporated Companies in our database. You can also find out about relevant Xencor Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record